
-
Cracking Cancer 2.0 - Introductory Remarks
Trond Undheim, PhD, Program Director, MIT Startup Exchange in collaboration with Anne Deconinck, PhD, Executive Director, MIT Koch Institute for Integrative Cancer Research
-
figur8
Nan-Wei Gong, Cofounder & CEO, figur8
-
Synthetic Biology Workshop 2017 - Industry View - Why We Care About New Materials
Vincent Ling, Senior Director, Materials and Innovation, Takeda
-
Sports, Nutrition & Wellness - Investor Keynote - David T. Thibodeau
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
-
DropWise Technologies
Adam Paxson, CEO; Annica Blake, COO; David Borrelli, CTO
Dropwise Technologies -
-
Cracking Cancer 2.0 - Panel Discussion
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
-
Cracking Cancer 2.0 - Cancer Innovation - The Long View
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
-
24M
Yet-Ming Chiang, Cofounder & Chief Scientist, 24M
Rick Feldt, President, 24M -
Accion Systems
Natalya Baily, CEO & Cofounder, Accion